Mead Johnson Nutrition (NYSE-Listed MJN ) visits the NYSE to celebrate its initial public offering. In honor of the occasion, Stephen W. Golsby, CEO, Mead Johnson Nutrition, and Management Committee ring The Opening BellSM.|
You can also download this bell to your desktop:
1. Right-click on the download link
2. Select "Save Target As"
3. Select download location and save.
Mead Johnson opens on the New York Stock Exchange today under the ticker symbol “MJN” after its successful IPO, in which it raised $720 million. Mead Johnson was formerly a division of Bristol-Myers Squibb Company, which is also listed on the NYSE under the symbol “BMY.”
About Mead Johnson Nutrition Company (NYSE: MJN)
Mead Johnson is a global leader in pediatric nutrition. The company develops, manufactures, markets and distributes more than 70 products in 50 markets world wide primarily under the “Enfa” family of brands, including Enfamil® infant formula. Its mission is to create nutritional brands and products trusted to give infants and children the best start in life. For more information or to download company and brand images and footage, please visit www.meadjohnson.com .